Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Jul;26(1):1–5. doi: 10.1111/j.1365-2125.1988.tb03356.x

Spontaneous reporting of adverse drug reactions. I: the data.

M D Rawlins 1
PMCID: PMC1386492  PMID: 3203052

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med. 1986 Jun;59(230):549–556. [PubMed] [Google Scholar]
  2. Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):930–932. doi: 10.1136/bmj.291.6500.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goetz C. G., Weiner W. J., Nausieda P. A., Klawans H. L. Tardive dyskinesia: pharmacology and clinical implications. Clin Neuropharmacol. 1982;5(1):3–22. [PubMed] [Google Scholar]
  4. Haward R. A. Scale of undernotification of infectious diseases by general practitioners. Lancet. 1973 Apr 21;1(7808):873–874. doi: 10.1016/s0140-6736(73)91433-5. [DOI] [PubMed] [Google Scholar]
  5. Inman W. H., Evans D. A. Evaluation of spontaneous reports of adverse reactions to drugs. Br Med J. 1972 Sep 23;3(5829):746–749. doi: 10.1136/bmj.3.5829.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–1505. doi: 10.1136/bmj.1.6075.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Inman W. H., Vessey M. P. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J. 1968 Apr 27;2(5599):193–199. doi: 10.1136/bmj.2.5599.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jenkinson D. Whooping cough: what proportion of cases is notified in an epidemic? Br Med J (Clin Res Ed) 1983 Jul 16;287(6386):185–186. doi: 10.1136/bmj.287.6386.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rawlins M. D. Spontaneous reporting of adverse drug reactions. II: Uses. Br J Clin Pharmacol. 1988 Jul;26(1):7–11. doi: 10.1111/j.1365-2125.1988.tb03357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rossi A. C., Hsu J. P., Faich G. A. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J (Clin Res Ed) 1987 Jan 17;294(6565):147–150. doi: 10.1136/bmj.294.6565.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Speirs C. J., Griffin J. P., Weber J. C., Glen-Bott M. Demography of the UK adverse reactions register of spontaneous reports. Health Trends. 1984 Aug;16(3):49–52. [PubMed] [Google Scholar]
  12. Venning G. R. Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) 1983 Jan 22;286(6361):289–292. doi: 10.1136/bmj.286.6361.289. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES